Medindia
☰
Why Register as Premium Member if you have Diabetes? Click Here
Medindia » Drug News

Indian Drug Major Sun Pharma Will Soon Launch a 'Diabetes Drug' in United States

by Dr. Trupti Shirole on August 3, 2016 at 3:42 PM

The generic version of Glumetza, Metformin Hydrochloride tablets - a diabetes drug - will soon be launched in the United States by Indian drug major Sun Pharmaceutical Industries Ltd.


The company said in a statement, that one of its subsidiaries got the final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for generic version of Glumetza, Metformin Hydrochloride extended release tablets 500 mg and 1,000 mg.

‘The generic version of Glumetza, Metformin Hydrochloride tablets - a diabetes drug - will soon be launched in the United States by Indian drug major Sun Pharmaceutical Industries Ltd.’

"These Metformin Hydrochloride extended release tablets are therapeutic equivalents of Santarus Inc's Glumetza tablets," the statement said.

The tablets may have an annual sales of around $1.2 billion in the US, the company added.

Source: IANS

View Non AMP Site | Back to top ↑